Hereditary breast cancer associated with a germline BRCA2 mutation in identical female twins with similar disease expression

被引:13
|
作者
Delgado, L
Fernández, G
González, A
Bressac-de Paillerets, B
Gualco, G
Bombled, J
Cataldi, S
Sabini, G
Roca, R
Musé, IM
机构
[1] Univ Republica, Hosp Clin, Serv Oncol Clin, Montevideo, Uruguay
[2] Univ Republica, Hosp Clin, Dept Basico Med, Montevideo, Uruguay
[3] Inst Gustave Roussy, Serv Genet, Villejuif, France
[4] Univ Republica, Hosp Clin, Dept Anat Patol, Montevideo, Uruguay
关键词
D O I
10.1016/S0165-4608(01)00541-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relative contribution of heritable and nonheritable factors to disease expression in BRCA2 mutation carriers is largely unknown. This report describes a familial breast cancer syndrome in a pair of identical female twins. These twins showed an extremely high concordance in their clinical histories: both twins exhibited similar cancer-related risk factors. and developed breast cancer at the same age with the same disease stage and identical histological features. No differences were detected in hormone receptors status, p53, bel-2, erbB-2 and LI Ki67 expression by immunohistochemistry. A BRCA2 exon 11 protein truncation test showed a lower molecular weight band than the one expected for a normal allele. in both twins, Sequence analysis of DNA showed a 6 bp insertion between nucleotides 4359-4360, which resulted in a premature stop codon at position 1378. The remarkable disease similarity observed in this identical twin pair is in accordance with an important role for heritable factors in disease expression among patients carrying BRCA germline mutations. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:24 / 28
页数:5
相关论文
共 50 条
  • [1] Survival in hereditary breast cancer associated with germline mutations of BRCA2
    Verhoog, LC
    Brekelmans, CTM
    Seynaeve, C
    Dahmen, G
    van Geel, AN
    Bartels, CCM
    Tilanus-Linthorst, MMA
    Wagner, A
    Devilee, P
    Halley, DJJ
    van den Ouweland, AMW
    Meijers-Heijboer, EJ
    Klijn, JGM
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3396 - 3402
  • [2] Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers
    Johannsson, O
    Loman, N
    Borg, Å
    Olsson, H
    LANCET, 1998, 352 (9137): : 1359 - 1360
  • [3] A case of gastric cancer metastasis to the breast in a female with BRCA2 germline mutation and literature review
    Dulskas, Audrius
    Al Bandar, Mahdi
    Choi, Yoon Young
    Shin, Su-Jin
    Beom, Seung-Hoon
    Son, Taeil
    Kim, Hyung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    ACTA CHIRURGICA BELGICA, 2019, 119 (01) : 59 - 63
  • [4] Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients
    Verhoog, LC
    Berns, EMJJ
    Brekelmans, CTM
    Seynaeve, C
    Meijers-Heijboer, EJ
    Klijn, JGM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 119S - 124S
  • [5] PARP inhibitors for hereditary breast cancer with germline BRCA mutation
    Im, Seock-Ah
    ANNALS OF ONCOLOGY, 2022, 33 : S423 - S423
  • [6] BRCA2 hereditary breast cancer pathophenotype
    Marcus, JN
    Watson, P
    Page, DL
    Narod, SA
    Tonin, P
    Lenoir, GM
    Serova, O
    Lynch, HT
    BREAST CANCER RESEARCH AND TREATMENT, 1997, 44 (03) : 275 - 277
  • [7] Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
    S M Edwards
    D G R Evans
    Q Hope
    A R Norman
    Y Barbachano
    S Bullock
    Z Kote-Jarai
    J Meitz
    A Falconer
    P Osin
    C Fisher
    M Guy
    S G Jhavar
    A L Hall
    L T O'Brien
    B N Gehr-Swain
    R A Wilkinson
    M S Forrest
    D P Dearnaley
    A T Ardern-Jones
    E C Page
    D F Easton
    R A Eeles
    British Journal of Cancer, 2010, 103 : 918 - 924
  • [8] Brca2 hereditary breast cancer pathophenotype
    Joseph N. Marcus
    Patrice Watson
    David L. Page
    Steven A. Narod
    Patricia Tonin
    Gilbert M. Lenoir
    Olga Serova
    Henry T. Lynch
    Breast Cancer Research and Treatment, 1997, 44 : 275 - 277
  • [9] Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
    Emiroglu, Selman
    Ozkurt, Enver
    Cabioglu, Neslihan
    Igci, Abdullah
    Saip, Pinar
    Yazici, Hulya
    Ozmen, Tolga
    Ozmen, Vahit
    Muslumanoglu, Mahmut
    Tukenmez, Mustafa
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 163 - 173
  • [10] Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
    Edwards, S. M.
    Evans, D. G. R.
    Hope, Q.
    Norman, A. R.
    Barbachano, Y.
    Bullock, S.
    Kote-Jarai, Z.
    Meitz, J.
    Falconer, A.
    Osin, P.
    Fisher, C.
    Guy, M.
    Jhavar, S. G.
    Hall, A. L.
    O'Brien, L. T.
    Gehr-Swain, B. N.
    Wilkinson, R. A.
    Forrest, M. S.
    Dearnaley, D. P.
    Ardern-Jones, A. T.
    Page, E. C.
    Easton, D. F.
    Eeles, R. A.
    BRITISH JOURNAL OF CANCER, 2010, 103 (06) : 918 - 924